Medfinder
Back to blog

Updated: January 28, 2026

How to Help Your Patients Save Money on Mavyret: A Provider's Guide to Savings Programs

Author

Peter Daggett

Peter Daggett

Mavyret blog header image

A comprehensive provider's guide to Mavyret savings programs in 2026—AbbVie copay cards, patient assistance, Medicare strategies, and foundation programs for every patient type.

Mavyret (glecaprevir/pibrentasvir) costs over $14,000 for an 8-week supply at cash price—but most patients should not pay anywhere near that amount. As a provider, knowing the financial assistance landscape for Mavyret allows you to ensure cost isn't what prevents your patients from completing this highly effective treatment.

This guide summarizes every major savings pathway for Mavyret in 2026, organized by insurance type so you can quickly identify the right resource for each patient.

Overview: Mavyret Financial Assistance by Coverage Type

Commercially insured: AbbVie Mavyret Savings Card → as low as $5/month

Uninsured/underinsured: myAbbVie Assist program → potentially $0

Medicare Part D: HealthWell Foundation, Good Days, Patient Advocate Foundation, and/or Low Income Subsidy (Extra Help)

Medicaid: Medicaid is required to cover Mavyret with minimal or no cost-sharing; PA required

Program 1: AbbVie Mavyret Savings Card (Commercial Insurance)

For commercially insured patients, the AbbVie savings card is the most impactful single intervention you can take. Eligible patients pay as little as $5 per prescription, with a lifetime maximum savings of up to $12,000.

Eligibility requirements:

Must have commercial (employer or marketplace) insurance that covers Mavyret

NOT eligible for patients with Medicare, Medicaid, or other government insurance

Must be a U.S. resident with a valid prescription for Mavyret

How to direct patients: mavyret.com/cost or call 1-877-628-9738. The card can be downloaded and printed or used digitally. Many specialty pharmacies will apply it automatically if it's on file.

Program 2: myAbbVie Assist (Uninsured or Underinsured)

For patients with no insurance or inadequate coverage, myAbbVie Assist is a comprehensive patient assistance program that can provide Mavyret at no cost to eligible patients.

Key points for providers:

Providers can initiate the application on behalf of patients

Patient must provide proof of income and residency

Medication is typically shipped to the prescriber's office or directly to the patient's home

Turnaround is typically 7–14 days from application approval

Contact: 1-800-222-6885 or AbbVie.com/PatientAccessSupport

Program 3: Medicare Part D Assistance

Medicare patients cannot use the AbbVie savings card, but several foundation programs fill this gap:

HealthWell Foundation Hepatitis C Fund: Helps cover Medicare Part D cost-sharing for HCV medications. 1-800-675-8416 or healthwellfoundation.org. Pediatric assistance also available.

Good Days from CancerCare: Requires insurance and valid prescription. 1-877-968-7233 or mygooddays.org.

Patient Advocate Foundation Co-Pay Relief: For patients with government insurance. Visit patientadvocate.org.

Medicare Low Income Subsidy (Extra Help): For eligible low-income Medicare patients, Extra Help reduces Part D costs to approximately $12 per month per drug. Apply through SSA at 1-800-772-1213 or ssa.gov/extrahelp.

Medicare in 2026: Key Changes Affecting Mavyret Patients

In 2026, the Medicare Part D out-of-pocket maximum is $2,100. Once a patient reaches this cap, their plan covers 100% of covered medication costs for the rest of the year. For patients who need Mavyret early in the calendar year and have high out-of-pocket costs, foundation programs can bridge the gap until the cap is reached.

Program 4: Medicaid Coverage

Medicaid plans are required to cover all FDA-approved drugs for their approved indications. Mavyret should be covered for Medicaid patients with minimal or zero out-of-pocket cost. Prior authorization is still required in most states. If a Medicaid patient faces barriers, consider:

Filing a PA on the patient's behalf with complete documentation

Requesting a peer-to-peer review if Medicaid denies the PA

Contacting the state Medicaid office or a patient advocacy organization if barriers persist

VA and Other Federal Coverage

The U.S. Department of Veterans Affairs covers hepatitis C treatment including Mavyret, Epclusa, and Harvoni for enrolled veterans diagnosed with HCV. If you treat veterans, encourage enrollment in VA health care for HCV patients who aren't already enrolled—they may access treatment with little or no out-of-pocket cost.

Quick Reference: Who to Call for Mavyret Savings

AbbVie patient/provider support (Mavyret HUB): 1-877-628-9738

myAbbVie Assist (PAP): 1-800-222-6885

HealthWell Foundation: 1-800-675-8416

Good Days: 1-877-968-7233

Social Security Extra Help: 1-800-772-1213

For providers looking to help patients locate Mavyret at pharmacies once cost is sorted, medfinder.com/providers can help identify which pharmacies near your patients have it in stock. For the full access picture, see our guide on what providers need to know about Mavyret access in 2026.

Frequently Asked Questions

Key savings programs include: (1) AbbVie Mavyret Savings Card for commercially insured patients — as low as $5/month, up to $12,000 lifetime; (2) myAbbVie Assist PAP for uninsured patients — potentially $0; (3) HealthWell Foundation Hepatitis C Fund for Medicare patients; (4) Good Days program for insured patients; and (5) Medicare Low Income Subsidy (Extra Help) for eligible Medicare patients.

Yes. Providers can initiate myAbbVie Assist applications on behalf of patients by calling 1-800-222-6885 or visiting AbbVie.com/PatientAccessSupport. You'll need to provide prescription information and the patient will need to supply proof of income and residency. Once approved, the medication is shipped to your office or directly to the patient.

Medicare patients cannot use the AbbVie commercial savings card. Options include: HealthWell Foundation Hepatitis C Fund (1-800-675-8416), Good Days program (1-877-968-7233), Patient Advocate Foundation Co-Pay Relief, and Medicare's Low Income Subsidy (Extra Help) for patients who qualify. The 2026 Medicare Part D cap of $2,100 also provides a ceiling on annual out-of-pocket costs.

Yes. Medicaid is required to cover all FDA-approved medications for their approved indications, including Mavyret for HCV. Most states require prior authorization. If a Medicaid patient faces access barriers, the prescriber should submit a PA with complete clinical documentation. Persistent denials can often be resolved via peer-to-peer review or state Medicaid appeals processes.

With commercial insurance that covers Mavyret and the AbbVie Savings Card applied, most eligible patients pay $5 per monthly fill. For an 8-week treatment course (which may involve 1–2 fills depending on dispensing), the out-of-pocket cost can be as low as $5–$10 total with the savings card. The lifetime savings limit is $12,000.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Mavyret also looked for:

Epclusa (sofosbuvir/velpatasvir)Harvoni (ledipasvir/sofosbuvir)Zepatier (elbasvir/grazoprevir)Vosevi (sofosbuvir/velpatasvir/voxilaprevir)

32,872 have already found their meds with Medfinder.

Start your search today.

32K+
5-star ratingTrusted by 32,872 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?